Phapros Joins the Moto GP Event in Mandalika, Lombok, NTB

Jakarta, March 18, 2022 – PT Phapros Tbk, which is one of the national pharmaceutical companies, participated in the Moto GP event at the Mandalika Circuit in Lombok, NTB.

The CEO of PT Phapros Tbk, Hadi Kardoko, stated that this is a form of Phapros' support for the international motorcycle race event by showcasing its superior health products in a trade promotion held for three days from Friday to Sunday (March 18-20, 2022).

"The Moto GP event in Mandalika is eagerly awaited by the entire Indonesian community. Through international events like this, and with a large number of spectators, we hope that the community can get to know our health products better," he said.

The Mandalika Moto GP is Indonesia's first Moto GP race since 1997 in Sentul, West Java. Indonesia became the third Southeast Asian country to be included in the Moto GP calendar this season along with Malaysia and Thailand.

On the other hand, the stock-coded issuer PEHA is optimistic about double-digit growth in 2022. This growth will mainly be driven by the development and innovation of new products. This year, Phapros plans to launch ten to twelve new products that are expected to drive the company's performance to meet its target.

To maintain product availability in the market, Phapros continues to make continuous improvements in all areas related to the business process, as well as collaborating with its subsidiary, PT Lucas Djaja Group.